Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Circulation Reports|November 21, 2022
Clinical Management and Outcomes of Patients With Portopulmonary Hypertension Enrolled in the Japanese Multicenter RegistryYudai Tamura, Yuichi Tamura, Yu Taniguchi, et al.
The European Respiratory Journal|December 7, 2023
Adult-onset idiopathic peripheral pulmonary artery stenosisYudai Tamura, Yuichi Tamura, Ayako Shigeta, et al.
Nature Cardiovascular Research|February 13, 2025
Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprinKen-Ichi Hirano, Satomi Okamura, Koichiro Sugimura, et al.
International Journal of Cardiology|September 17, 2022
Usefulness of cardiac magnetic resonance for early detection of cancer therapeutics-related cardiac dysfunction in breast cancer patientsYosuke Terui, Koichiro Sugimura, Hideki Ota, et al.
Pulmonary Circulation|June 26, 2025
Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone TreatmentTaijyu Satoh, Yuichi Tamura, Noriaki Takama, et al.
European Heart Journal Open|June 12, 2026
Asymptomatic and symptomatic cardiac toxicity associated with immune checkpoint inhibitors: insights from a Japanese registryYudai Tamura, Yuichi Tamura, Hiroshi Ohtsu, et al.
JACC. Asia|May 20, 2024
Pulmonary Hypertension With Interstitial Pneumonia: Initial Treatment Effectiveness and Severity in a Japan RegistryNobuhiro Tanabe, Hiraku Kumamaru, Yuichi Tamura, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 16, 2018
Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 14, 2018
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 8, 2019
Correction: Effectiveness of plasma lyso-Gb3 as a biomarker for selecting high-risk patients with Fabry disease from multispecialty clinics for genetic analysisHiroki Maruyama, Kaori Miyata, Mariko Mikame, et al.
Pageof 11